These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12815750)

  • 1. Apolipoprotein E Pittsburgh variant is not associated with the risk of late-onset Alzheimer's disease in a Spanish population.
    Baron M; Jimenez-Escrig A; Orensanz L; Simon J; Perez-Tur J
    Am J Med Genet B Neuropsychiatr Genet; 2003 Jul; 120B(1):121-4. PubMed ID: 12815750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease.
    Kamboh MI; Aston CE; Perez-Tur J; Kokmen E; Ferrell RE; Hardy J; DeKosky ST
    Neurosci Lett; 1999 Mar; 263(2-3):129-32. PubMed ID: 10213152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk].
    Hernández-Charro B; Moreno S; Valiente A; Manubens JM; Villar MD; Ramos-Arroyo MA
    Med Clin (Barc); 2004 Sep; 123(7):251-4. PubMed ID: 15482730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
    Cui T; Zhou X; Jin W; Zheng F; Cao X
    Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E: risk factor for Alzheimer disease.
    Tsai MS; Tangalos EG; Petersen RC; Smith GE; Schaid DJ; Kokmen E; Ivnik RJ; Thibodeau SN
    Am J Hum Genet; 1994 Apr; 54(4):643-9. PubMed ID: 8128961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.
    Rodríguez E; Mateo I; Infante J; Llorca J; Berciano J; Combarros O
    J Neurol; 2006 Feb; 253(2):181-5. PubMed ID: 16096813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
    Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
    J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population.
    Ezquerra M; Blesa R; Tolosa E; Ballesta F; Oliva R
    Neurosci Lett; 1998 Jan; 240(2):107-9. PubMed ID: 9486483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
    Ki CS; Na DL; Kim JW; Kim HJ; Kim DK; Yoon BK
    Am J Med Genet; 1999 Apr; 88(2):113-5. PubMed ID: 10206226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region.
    Chartier-Harlin MC; Parfitt M; Legrain S; Pérez-Tur J; Brousseau T; Evans A; Berr C; Vidal O; Roques P; Gourlet V
    Hum Mol Genet; 1994 Apr; 3(4):569-74. PubMed ID: 8069300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease.
    Lehmann DJ; Johnston C; Smith AD
    Hum Mol Genet; 1997 Oct; 6(11):1933-6. PubMed ID: 9302273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes.
    D'Onofrio G; Panza F; Seripa D; Sancarlo D; Paris F; Cascavilla L; Urbano M; Gravina C; Fontana A; Solfrizzi V; Pellegrini F; Pilotto A
    Int J Geriatr Psychiatry; 2011 Oct; 26(10):1062-70. PubMed ID: 21905100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E4 allele frequency in Spanish Alzheimer and control cases.
    Adroer R; Santacruz P; Blesa R; López-Pousa S; Ascaso C; Oliva R
    Neurosci Lett; 1995 Apr; 189(3):182-6. PubMed ID: 7624040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
    Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease.
    Lehtimäki T; Pirttilä T; Mehta PD; Wisniewski HM; Frey H; Nikkari T
    Hum Genet; 1995 Jan; 95(1):39-42. PubMed ID: 7814023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers.
    Ramirez-Lorca R; Boada M; Saez ME; Hernandez I; Mauleon A; Rosende-Roca M; Martinez-Lage P; Gutierrez M; Real LM; Lopez-Arrieta J; Gayan J; Antunez C; Gonzalez-Perez A; Tarraga L; Ruiz A
    J Nutr Health Aging; 2009 Mar; 13(3):214-9. PubMed ID: 19262956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genotype 2/2 of the presenilin-1 polymorphism is decreased in Spanish early-onset Alzheimer's disease.
    Ezquerra M; Blesa R; Tolosa E; Lopez Pousa S; Aguilar M; Peña J; Van Broeckhoven C; Ballesta F; Oliva R
    Neurosci Lett; 1997 May; 227(3):201-4. PubMed ID: 9185685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.